ABSTRACT: Co-culture confrontation assays of Acinetobacter baumannii vs. other multi-drug resistance organisms or vs. human dermal fibroblasts. Transcriptome
Project description:Co-culture confrontation assays of Acinetobacter baumannii vs. other multi-drug resistance organisms or vs. human dermal fibroblasts. transcriptome
Project description:Co-culture confrontation assays of Klebsiella pneumoniae vs. other multi-drug resistance organisms or vs. human dermal fibroblasts. transcriptome
Project description:Co-culture confrontation assays of Enterobacter cloacae vs. other multi-drug resistance organisms or vs. human dermal fibroblasts. transcriptome
Project description:Co-culture confrontation assays of commercially available cultured adult human dermal fibroblasts (HDFa) vs. multi-drug resistant bacteria
Project description:Acinetobacter baumannii causes high mortality in ventilator-associated pneumonia patients and antibiotic treatment is compromised in multi-drug resistant strains resistant to beta-lactams, carbapenems, cephalosporins, polymyxins and tetracyclines. Among COVID-19 patients receiving ventilator support, multi-drug resistant A. baumannii secondary infection is associated with a two-fold increase in mortality. Here we investigated the use of the 8-hydroxyquinoline ionophore PBT2 to break resistance of A. baumannii to tetracycline class antibiotics.
Project description:Gene expression analysis of BJhTERT RhoA-KO and PC3 mRFP was performed before and after six days confrontation in co-cultivation. Analyses of original and control fibroblasts was also performed. To identify molecules that may mediate the tumor promoting effect of RhoA knock out fibroblasts, we performed gene expression analysis of BJhTERT RhoA-KO and PC3 mRFP cells before the confrontation and then after six days after it, using Affymetrix Whole Transcript Assay platform.
Project description:Gene expression analysis of BJhTERT RhoA-KO and PC3 mRFP was performed before and after six days confrontation in co-cultivation. Analyses of original and control fibroblasts was also performed. To identify molecules that may mediate the tumor promoting effect of RhoA knock out fibroblasts, we performed gene expression analysis of BJhTERT RhoA-KO and PC3 mRFP cells before the confrontation and then after six days after it, using Affymetrix Whole Transcript Assay platform. Four days old fibroblast monolayer was confronted with PC3 mRFP tumor cells, plated in ratio 1:30 to number of plated fibroblasts. After six days of confrontation cells were sorted by FACS (Fluorescence-activated cell sorting). Total RNA was isolated from each confronted and non-confronted cells with kit. Then 150 ng of total RNA were used for transcriptomic analysis.for RNA extraction and hybridization on Affymetrix microarrays
